Aruna Bio's Co-Founder Dr. Steven Stice has been inducted into the 2025 AIMBE College of Fellows, recognizing his pioneering work in stem cell biology and extracellular vesicles for treating neurodegenerative diseases...
Read More »Aruna Bio Awarded $4.5 Million SBIR Phase II Grant to Support Development of Neural Exosome AB126
Aruna Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the company has been awarded a Small Business Innovation Research (SBIR) Phase II grant by the National Institutes of Health in ...
Read More »ArunA Bio Raises $5.3 Million to fuel growth and innovation for its neural exosome therapeutic platform
ArunA Bio today announced that it has secured $5.3 million to further the development of its neural exosome therapeutic platform and manufacturing processes for a broad range of neurological disorders. The funding was raised from existing angel investors. ArunA’s neural ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
